商务合作
动脉网APP
可切换为仅中文
AbstractOver the past decade, genome-scale molecular profiling of large childhood cancer survivorship cohorts has led to unprecedented advances in our understanding of the genetic and epigenetic bases of therapy-related adverse health outcomes in this vulnerable population. To facilitate the integration of knowledge generated from these studies into formulating next-generation precision care for survivors of childhood cancer, we summarize key findings of genetic and epigenetic association studies of long-term therapy-related adverse effects including subsequent neoplasms and cardiomyopathies among others.
摘要在过去的十年中,大型儿童癌症幸存者队列的基因组规模分子谱分析使我们对这一弱势人群中与治疗相关的不良健康结果的遗传和表观遗传基础的理解取得了前所未有的进展。为了促进将这些研究产生的知识整合到为儿童癌症幸存者制定下一代精准护理中,我们总结了长期治疗相关不良反应(包括随后的肿瘤和心肌病等)的遗传和表观遗传关联研究的关键发现。
We also discuss therapy-related genotoxicities including clonal haematopoiesis and DNA methylation, which may underlie accelerated molecular ageing. Finally, we highlight enhanced risk prediction models for survivors of childhood cancer that incorporate both genetic factors and treatment exposures, aiming to achieve enhanced accuracy in predicting risks for this population.
我们还讨论了与治疗相关的基因毒性,包括克隆造血和DNA甲基化,这可能是加速分子衰老的基础。最后,我们重点介绍了儿童癌症幸存者的增强风险预测模型,该模型结合了遗传因素和治疗暴露,旨在提高预测该人群风险的准确性。
These new insights will hopefully inspire future studies that harness both expanding omics resources and evolving data science methodology to accelerate the translation of precision medicine for survivors of childhood cancer..
这些新的见解有望激发未来的研究,利用不断扩大的组学资源和不断发展的数据科学方法,加速为儿童癌症幸存者翻译精准医学。。
Access through your institution
通过您的机构访问
Buy or subscribe
购买或订阅
This is a preview of subscription content, access via your institution
这是订阅内容的预览,可通过您的机构访问
Access options
访问选项
Access through your institution
通过您的机构访问
Access through your institution
通过您的机构访问
Change institution
变革机构
Buy or subscribe
购买或订阅
Access Nature and 54 other Nature Portfolio journalsGet Nature+, our best-value online-access subscription24,99 € / 30 dayscancel any timeLearn moreSubscription info for Chinese customersWe have a dedicated website for our Chinese customers. Please go to naturechina.com to subscribe to this journal.Go to naturechina.comBuy this articlePurchase on SpringerLinkInstant access to full article PDFBuy nowPrices may be subject to local taxes which are calculated during checkout.
Access Nature和54篇其他Nature Portfolio journalsGet Nature+,我们最有价值的在线订阅24,99欧元/30天,随时为中国客户获取更多订阅信息我们为中国客户提供了一个专门的网站。请访问naturechina.com订阅本期刊。访问naturechina.comBuy本文在Springerlink上购买即时访问完整文章PDFBuy Now价格可能需要缴纳结帐时计算的地方税。
Additional access options:
其他访问选项:
Log in
登录
Learn about institutional subscriptions
了解机构订阅
Read our FAQs
阅读我们的常见问题
Contact customer support
联系客户支持
Fig. 1: Genetic contributions to adverse late effects in survivors of childhood cancer.Fig. 2: Established host genetic risk factors and their implicated biological pathways for subsequent breast cancer, subsequent thyroid cancer and cardiomyopathy among survivors of childhood cancer.Fig. 3: Interactions between ageing biomarkers, risk factors and chronic health conditions.Fig.
图1:对儿童癌症幸存者不良晚期影响的遗传贡献。图2:儿童癌症幸存者中确定的宿主遗传危险因素及其与随后的乳腺癌,随后的甲状腺癌和心肌病有关的生物学途径。图3:衰老生物标志物,危险因素和慢性健康状况之间的相互作用。图。
4: A scheme for future research into cancer survivorship..
4: 未来癌症幸存者研究计划。。
Data availability
数据可用性
Previously published data were used for plotting graphs in Figs. 1 and 3. Details can be found in each of the corresponding figure legends.
先前发布的数据用于绘制图1和图3中的图形。详细信息可以在每个相应的图例中找到。
ReferencesRobison, L. L. & Hudson, M. M. Survivors of childhood and adolescent cancer: life-long risks and responsibilities. Nat. Rev. Cancer 14, 61–70 (2014).Article
参考文献Robison,L.L。和Hudson,M.M。儿童和青少年癌症的幸存者:终身风险和责任。《自然评论》癌症14,61-70(2014)。文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Gibson, T. M. et al. Temporal patterns in the risk of chronic health conditions in survivors of childhood cancer diagnosed 1970–99: a report from the Childhood Cancer Survivor Study cohort. Lancet Oncol. 19, 1590–1601 (2018).Article
Gibson,T.M.等人,《1970-99年确诊的儿童癌症幸存者慢性健康状况风险的时间模式:儿童癌症幸存者研究队列的报告》。柳叶刀Oncol。191590-1601(2018)。文章
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Ehrhardt, M. J. et al. Improving quality and quantity of life for childhood cancer survivors globally in the twenty-first century. Nat. Rev. Clin. Oncol. 20, 678–696 (2023).Article
Ehrhardt,M.J.等人,《在二十一世纪提高全球儿童癌症幸存者的生活质量和数量》。国家修订临床。Oncol公司。20678-696(2023)。文章
PubMed
PubMed
Google Scholar
谷歌学者
Bhakta, N. et al. The cumulative burden of surviving childhood cancer: an initial report from the St Jude Lifetime Cohort Study (SJLIFE). Lancet 390, 2569–2582 (2017).Article
Bhakta,N.等人,《存活儿童癌症的累积负担:圣裘德终身队列研究(SJLIFE)的初步报告》。柳叶刀3902569-2582(2017)。文章
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Ehrhardt, M. J. et al. Association of modifiable health conditions and social determinants of health with late mortality in survivors of childhood cancer. JAMA Netw. Open. 6, e2255395 (2023).Article
Ehrhardt,M.J.等人,《可改变的健康状况和健康的社会决定因素与儿童癌症幸存者晚期死亡率的关系》。JAMA网络。打开。6,e2255395(2023)。文章
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Dixon, S. B. et al. Specific causes of excess late mortality and association with modifiable risk factors among survivors of childhood cancer: a report from the Childhood Cancer Survivor Study cohort. Lancet 401, 1447–1457 (2023).Article
Dixon,S.B.等人,《儿童癌症幸存者研究队列中晚期死亡率过高的具体原因及其与可改变危险因素的关联:儿童癌症幸存者研究队列的报告》。柳叶刀4011447-1457(2023)。文章
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Lipshultz, S. E. et al. Long-term cardiovascular toxicity in children, adolescents, and young adults who receive cancer therapy: pathophysiology, course, monitoring, management, prevention, and research directions: a scientific statement from the American Heart Association. Circulation 128, 1927–1995 (2013).Article .
Lipshultz,S.E.等人,《接受癌症治疗的儿童、青少年和年轻人的长期心血管毒性:病理生理学、过程、监测、管理、预防和研究方向:美国心脏协会的科学声明》。发行量1281927–1995(2013)。文章。
PubMed
PubMed
Google Scholar
谷歌学者
Armenian, S. H. et al. Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group. Lancet Oncol. 16, e123–e136 (2015).Article
Armenian,S.H.等人,《儿童癌症幸存者心肌病监测建议:国际儿童癌症晚期影响指南协调小组的报告》。柳叶刀Oncol。16,e123–e136(2015)。文章
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Mulrooney, D. A. et al. Cardiac outcomes in adult survivors of childhood cancer exposed to cardiotoxic therapy: a cross-sectional study. Ann. Intern. Med. 164, 93–101 (2016).Article
Mulrooney,D.A.等人。暴露于心脏毒性治疗的儿童癌症成年幸存者的心脏结局:横断面研究。安,实习生。医学杂志16493-101(2016)。文章
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Moskowitz, C. S. et al. Breast cancer after chest radiation therapy for childhood cancer. J. Clin. Oncol. 32, 2217–2223 (2014).Article
Moskowitz,C.S.等人。儿童癌症胸部放射治疗后的乳腺癌。J、 临床。Oncol公司。322217–2223(2014)。文章
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Ehrhardt, M. J. et al. Subsequent breast cancer in female childhood cancer survivors in the St Jude Lifetime Cohort Study (SJLIFE). J. Clin. Oncol. 37, 1647–1656 (2019).Article
Ehrhardt,M.J.等人,《St Jude终身队列研究(SJLIFE)中女性儿童癌症幸存者的后续乳腺癌》。J、 临床。Oncol公司。371647-1656(2019)。文章
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Wang, Y. et al. Subsequent female breast cancer risk associated with anthracycline chemotherapy for childhood cancer. Nat. Med. 29, 2268–2277 (2023).Article
Wang,Y.等人。随后与儿童癌症蒽环类化疗相关的女性乳腺癌风险。《自然医学》292268-2277(2023)。文章
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Henderson, T. O. et al. Breast cancer risk in childhood cancer survivors without a history of chest radiotherapy: a report from the Childhood Cancer Survivor Study. J. Clin. Oncol. 34, 910–918 (2016).Article
Henderson,T.O.等人,《没有胸部放疗史的儿童癌症幸存者的乳腺癌风险:儿童癌症幸存者研究报告》。J、 临床。Oncol公司。34910–918(2016)。文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Veiga, L. H. et al. Association of breast cancer risk after childhood cancer with radiation dose to the breast and anthracycline use: a report from the Childhood Cancer Survivor Study. JAMA Pediatr. 173, 1171–1179 (2019).Article
Veiga,L.H.等人,《儿童癌症后乳腺癌风险与乳腺辐射剂量和蒽环类药物使用的关系:儿童癌症幸存者研究报告》。JAMA儿科。1731171-1179(2019)。文章
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Bashore, L. & Hobbie, W. Emerging and ongoing survivorship challenges among childhood cancer survivors and providing risk-based focused follow-up care. Semin. Oncol. Nurs. 37, 151163 (2021).Article
Bashore,L。&Hobbie,W。儿童癌症幸存者中新兴和持续的生存挑战,并提供基于风险的重点随访护理。塞米。Oncol公司。护士。37151163(2021)。文章
PubMed
PubMed
Google Scholar
谷歌学者
Forster, V. J. What cancer survivors can teach cancer researchers. Nat. Rev. Cancer 22, 431–432 (2022).Article
Forster,V.J。癌症幸存者可以教会癌症研究人员什么。。文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Qin, N. et al. Pathogenic germline mutations in DNA repair genes in combination with cancer treatment exposures and risk of subsequent neoplasms among long-term survivors of childhood cancer. J. Clin. Oncol. 38, 2728–2740 (2020).Article
秦,N。等人。DNA修复基因中的致病性种系突变与儿童癌症长期幸存者的癌症治疗暴露和随后的肿瘤风险相结合。J、 临床。Oncol公司。382728-2740(2020)。文章
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Song, N. et al. Persistent variations of blood DNA methylation associated with treatment exposures and risk for cardiometabolic outcomes in long-term survivors of childhood cancer in the St. Jude Lifetime Cohort. Genome Med. 13, 53 (2021).Article
Song,N.等人。在圣裘德终身队列中,儿童癌症长期幸存者的血液DNA甲基化持续变化与治疗暴露和心脏代谢结局风险相关。基因组医学13,53(2021)。文章
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Hagiwara, K. et al. Dynamics of age- versus therapy-related clonal hematopoiesis in long-term survivors of pediatric cancer. Cancer Discov. 13, 844–857 (2023). This work is the first large-scale study of CH in long-term survivors of childhood cancer.Article
Hagiwara,K。等人。儿童癌症长期幸存者中年龄与治疗相关克隆造血的动态。癌症发现。13844-857(2023)。这项工作是对儿童癌症长期幸存者进行CH的首次大规模研究。文章
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Morton, L. M. et al. Genome-wide association study to identify susceptibility loci that modify radiation-related risk for breast cancer after childhood cancer. J. Natl Cancer Inst. 109, djx058 (2017).Article
Morton,L.M.等人进行了全基因组关联研究,以确定可改变儿童癌症后乳腺癌辐射相关风险的易感基因座。J、 。文章
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Wang, Z. et al. Genetic risk for subsequent neoplasms among Long-term survivors of childhood cancer. J. Clin. Oncol. 36, 2078–2087 (2018). This work presents the first WGS dataset on a childhood cancer survivorship cohort, with the data used in many follow-up genetic studies, and presents the first comprehensive analysis of the risk conferred by cancer predisposing variants, stratified by exposure to radiation, to subsequent neoplasms.Article .
Wang,Z.等人。儿童癌症长期幸存者中后续肿瘤的遗传风险。J、 临床。Oncol公司。362078-2087(2018)。这项工作介绍了关于儿童癌症幸存者队列的第一个WGS数据集,以及许多后续遗传研究中使用的数据,并首次全面分析了癌症易感变异(按辐射暴露分层)对随后肿瘤的风险。文章。
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Kim, J. et al. Frequency of pathogenic germline variants in cancer-susceptibility genes in the Childhood Cancer Survivor Study. JNCI Cancer Spectr. 5, pkab007 (2021). This work presents a large-scale WES dataset generated with the largest cohort of survivors of childhood cancer in North America, and has been used as a data resource in many of the subsequent studies.Article .
Kim,J.等人,《儿童癌症幸存者研究中癌症易感基因中致病种系变异的频率》。JNCI癌症谱。5,pkab007(2021)。这项工作提供了一个大规模的WES数据集,该数据集是由北美最大的儿童癌症幸存者队列生成的,并已被用作许多后续研究的数据资源。文章。
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Hudson, M. M. et al. Clinical ascertainment of health outcomes among adults treated for childhood cancer. JAMA 309, 2371–2381 (2013).Article
Hudson,M.M.等人。儿童癌症治疗成人健康结局的临床确定。。文章
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Robison, L. L. et al. The Childhood Cancer Survivor Study: a National Cancer Institute-supported resource for outcome and intervention research. J. Clin. Oncol. 27, 2308–2318 (2009).Article
Robison,L.L.等人,《儿童癌症幸存者研究:国家癌症研究所支持的结果和干预研究资源》。J、 临床。Oncol公司。272308-2318(2009)。文章
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Waespe, N. et al. Cohort-based association study of germline genetic variants with acute and chronic health complications of childhood cancer and its treatment: Genetic Risks for Childhood Cancer Complications Switzerland (GECCOS) study protocol. BMJ Open 12, e052131 (2022).Article
Waespe,N.等人。基于队列的种系遗传变异与儿童癌症急性和慢性健康并发症及其治疗的关联研究:瑞士儿童癌症并发症的遗传风险(GECCOS)研究方案。BMJ公开赛12,e052131(2022)。文章
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
McLeod, C. et al. St. Jude Cloud: a pediatric cancer genomic data-sharing ecosystem. Cancer Discov. 11, 1082–1099 (2021).Article
McLeod,C.等人,《圣裘德云:儿科癌症基因组数据共享生态系统》。癌症发现。11082-1099(2021)。文章
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Flores-Toro, J. A. et al. The Childhood Cancer Data Initiative: using the power of data to learn from and improve outcomes for every child and young adult with pediatric cancer. J. Clin. Oncol. 41, 4045–4053 (2023).Article
Flores Toro,J.A.等人,《儿童癌症数据倡议:利用数据的力量向每一个患有儿科癌症的儿童和年轻人学习并改善其结果》。J、 临床。Oncol公司。414045-4053(2023)。文章
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Im, C. et al. Generalizability of “GWAS hits” in clinical populations: lessons from childhood cancer survivors. Am. J. Hum. Genet. 107, 636–653 (2020).Article
Im,C.等人,“GWAS命中”在临床人群中的普遍性:来自儿童癌症幸存者的教训。上午J。嗯。Genet。。文章
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Goodenough, C. G. et al. Association between CEP72 genotype and persistent neuropathy in survivors of childhood acute lymphoblastic leukemia. Leukemia 36, 1160–1163 (2022).Article
Goodenough,C.G.等人。儿童急性淋巴细胞白血病幸存者中CEP72基因型与持续性神经病之间的关联。白血病361160-1163(2022)。文章
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
van Dorp, W. et al. Genetic variation may modify ovarian reserve in female childhood cancer survivors. Hum. Reprod. 28, 1069–1076 (2013).Article
遗传变异可能会改变女性儿童癌症幸存者的卵巢储备。哼。责备。281069-1076(2013)。文章
PubMed
PubMed
Google Scholar
谷歌学者
van der Kooi, A. L. F. et al. Possible modification of BRSK1 on the risk of alkylating chemotherapy-related reduced ovarian function. Hum. Reprod. 36, 1120–1133 (2021).Article
。哼。责备。361120-1133(2021)。文章
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
van der Perk, M. E. M. et al. Effect of genetic variation in CYP450 on gonadal impairment in a European cohort of female childhood cancer survivors, based on a candidate gene approach: results from the PanCareLIFE study. Cancers 13, 4598 (2021). This work is a genetic study conducted with a European cohort of survivors of childhood cancer.Article .
van der Perk,M.E.M.等人。基于候选基因方法,CYP450基因变异对欧洲女性儿童癌症幸存者队列性腺损伤的影响:PanCareLIFE研究的结果。癌症134598(2021)。这项工作是一项针对欧洲儿童癌症幸存者队列的基因研究。文章。
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Sapkota, Y. et al. Whole-genome sequencing of childhood cancer survivors treated with cranial radiation therapy identifies 5p15.33 locus for stroke: a report from the St. Jude Lifetime Cohort Study. Clin. Cancer Res. 25, 6700–6708 (2019).Article
Sapkota,Y.等人。接受头颅放射治疗的儿童癌症幸存者的全基因组测序确定了中风的5p15.33位点:来自圣裘德终身队列研究的报告。临床。癌症研究256700-6708(2019)。文章
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Im, C. et al. Genome-wide association studies reveal novel locus with sex-/therapy-specific fracture risk effects in childhood cancer survivors. J. Bone Min. Res. 36, 685–695 (2021).Article
全基因组关联研究揭示了儿童癌症幸存者中具有性别/治疗特异性骨折风险影响的新基因座。J、 Bone Min.Res.36685–695(2021)。文章
CAS
中科院
Google Scholar
谷歌学者
Wilson, C. L. et al. Genetic and clinical factors associated with obesity among adult survivors of childhood cancer: a report from the St. Jude Lifetime Cohort. Cancer 121, 2262–2270 (2015).Article
Wilson,C.L.等人,《儿童癌症成年幸存者中与肥胖相关的遗传和临床因素:来自圣裘德终身队列的报告》。癌症1212262-2270(2015)。文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Richard, M. A. et al. Germline genetic and treatment-related risk factors for diabetes mellitus in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study and St Jude Lifetime Cohorts. JCO Precis. Oncol. 6, e2200239 (2022).Article
Richard,M.A.等人,《儿童癌症幸存者中糖尿病的种系遗传和治疗相关危险因素:儿童癌症幸存者研究和圣裘德终身队列的报告》。JCO Precis公司。Oncol公司。6,e2200239(2022)。文章
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Petrykey, K. et al. Genetic factors and long-term treatment-related neurocognitive deficits, anxiety, and depression in childhood leukemia survivors: an exome-wide association study. Cancer Epidemiol. Biomark. Prev. 33, 234–243 (2024).Article
儿童白血病幸存者的遗传因素和长期治疗相关的神经认知缺陷、焦虑和抑郁:一项全基因组关联研究。癌症流行病学。生物标志物。33234-243(2024)。文章
CAS
中科院
Google Scholar
谷歌学者
Sapkota, Y. et al. Contribution of genome-wide polygenic score to risk of coronary artery disease in childhood cancer survivors. JACC CardioOncol 4, 258–267 (2022).Article
Sapkota,Y.等人。全基因组多基因评分对儿童癌症幸存者冠状动脉疾病风险的贡献。。文章
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Sapkota, Y. et al. Contribution of polygenic risk to hypertension among long-term survivors of childhood cancer. JACC CardioOncol 3, 76–84 (2021).Article
Sapkota,Y.等人。儿童癌症长期幸存者中多基因风险对高血压的贡献。JACC CardioOncol 3,76-84(2021)。文章
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Wang, Z. et al. Association of germline BRCA2 mutations with the risk of pediatric or adolescent non-Hodgkin lymphoma. JAMA Oncol. 5, 1362–1364 (2019).Article
Wang,Z.等人。种系BRCA2突变与儿童或青少年非霍奇金淋巴瘤风险的关联。JAMA Oncol。51362-1364(2019)。文章
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Chen, C. et al. Cancer germline predisposing variants and late mortality from subsequent malignant neoplasms among long-term childhood cancer survivors: a report from the St Jude Lifetime Cohort and the Childhood Cancer Survivor Study. Lancet Oncol. 24, 1147–1156 (2023). This large-scale study with more than 12,000 survivors of childhood cancer obtained by combining cohorts extended the finding of second cancer risk conferred by rare cancer predisposing variants to second cancer-related mortality.Article .
。柳叶刀Oncol。241147-1156(2023)。这项大规模研究通过结合队列获得了12000多名儿童癌症幸存者,将罕见的癌症易感变异所带来的第二种癌症风险的发现扩展到了第二种癌症相关死亡率。文章。
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Morton, L. M. et al. Subsequent neoplasm risk associated with rare variants in DNA damage response and clinical radiation sensitivity syndrome genes in the Childhood Cancer Survivor Study. JCO Precis. Oncol. 4, PO.20.00141 (2020).PubMed
Morton,L.M.等人,《儿童癌症幸存者研究中与DNA损伤反应和临床放射敏感性综合征基因罕见变异相关的后续肿瘤风险》。JCO Precis公司。Oncol公司。4,PO.20.00141(2020)。PubMed出版社
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Sapkota, Y. et al. Genome-wide association study in irradiated childhood cancer survivors identifies HTR2A for subsequent basal cell carcinoma. J. Invest. Dermatol. 139, 2042–2045.e8 (2019).Article
Sapkota,Y。等人。在受照射的儿童癌症幸存者中进行的全基因组关联研究确定了HTR2A用于随后的基底细胞癌。J、 投资。皮肤病。1392042-2045.e8(2019)。文章
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Opstal-van Winden, A. W. J. et al. Genetic susceptibility to radiation-induced breast cancer after Hodgkin lymphoma. Blood 133, 1130–1139 (2019).Article
Opstal van Winden,A.W.J.等人。霍奇金淋巴瘤后放射性乳腺癌的遗传易感性。血液1331130-1139(2019)。文章
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Cho, S. W. et al. Promoter of lncRNA gene PVT1 is a tumor-suppressor DNA boundary element. Cell 173, 1398–1412.e22 (2018).Article
。细胞1731398-1412.e22(2018)。文章
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Dhanasekaran, R. et al. The MYC oncogene—the grand orchestrator of cancer growth and immune evasion. Nat. Rev. Clin. Oncol. 19, 23–36 (2022).Article
Dhanasekaran,R。等人。MYC癌基因是癌症生长和免疫逃避的主要协调者。国家修订临床。Oncol公司。19,23-36(2022)。文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Wang, Z. et al. Polygenic determinants for subsequent breast cancer risk in survivors of childhood cancer: the St Jude Lifetime Cohort Study (SJLIFE). Clin. Cancer Res. 24, 6230–6235 (2018).Article
Wang,Z.等人。儿童癌症幸存者后续乳腺癌风险的多基因决定因素:圣裘德终身队列研究(SJLIFE)。临床。癌症研究246230-6235(2018)。文章
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Gibson, T. M. et al. Polygenic risk scores, radiation treatment exposures and subsequent cancer risk in childhood cancer survivors. Nat. Med. 30, 690–698 (2024). This study examines the interactions between a PRS and radiation therapy in contributing to the risk of developing subsequent neoplasms among survivors of childhood cancer.Article .
Gibson,T.M.等人,《儿童癌症幸存者的多基因风险评分、放射治疗暴露和随后的癌症风险》。《自然医学》30690-698(2024)。这项研究调查了PRS和放射治疗之间的相互作用,以增加儿童癌症幸存者发生后续肿瘤的风险。文章。
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Fritsche, L. G. et al. Cancer PRSweb: an online repository with polygenic risk scores for major cancer traits and their evaluation in two independent biobanks. Am. J. Hum. Genet. 107, 815–836 (2020).Article
Fritsche,L.G.等人,《癌症PRSweb:一个在线存储库,其中包含主要癌症特征的多基因风险评分及其在两个独立生物库中的评估》。上午J。嗯。Genet。107815-836(2020)。文章
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Im, C. et al. Polygenic risk and chemotherapy-related subsequent malignancies in childhood cancer survivors: a childhood cancer survivor study and St Jude Lifetime Cohort Study Report. J. Clin. Oncol. 41, 4381–4393 (2023). This study reports that a PRS constructed from genetic variants associated with pleiotropic adult cancer risk can further stratify risk of subsequent malignancies among non-irradiated survivors of childhood cancer.Article .
Im,C.等人,《儿童癌症幸存者的多基因风险和化疗相关后续恶性肿瘤:儿童癌症幸存者研究和圣裘德终身队列研究报告》。J、 临床。Oncol公司。414381-4393(2023)。这项研究报告说,由与多效性成人癌症风险相关的遗传变异构建的PRS可以进一步分层未受照射的儿童癌症幸存者中后续恶性肿瘤的风险。文章。
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Wang, X. et al. CELF4 variant and anthracycline-related cardiomyopathy: a Children’s Oncology Group genome-wide association study. J. Clin. Oncol. 34, 863–870 (2016).Article
Wang,X。等。CELF4变异与蒽环类药物相关性心肌病:儿童肿瘤组全基因组关联研究。J、 临床。Oncol公司。34863-870(2016)。文章
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Hayes, J. D., Flanagan, J. U. & Jowsey, I. R. Glutathione transferases. Annu. Rev. Pharmacol. Toxicol. 45, 51–88 (2005).Article
Hayes,J.D.,Flanagan,J.U.和Jowsey,I.R.谷胱甘肽转移酶。年。药理学修订版。有毒物质。45, 51-88 (2005).文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Singh, P. et al. Association of GSTM1 null variant with anthracycline-related cardiomyopathy after childhood cancer—a Children’s Oncology Group ALTE03N1 report. Cancer 126, 4051–4058 (2020).Article
Singh,P。等人。儿童癌症后GSTM1无效变异与蒽环类相关性心肌病的关联-儿童肿瘤学小组ALTE03N1报告。癌症1264051-4058(2020)。文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Bhatia, S. Genetics of anthracycline cardiomyopathy in cancer survivors: JACC: CardioOncology State-of-the-Art Review. JACC CardioOncol 2, 539–552 (2020).Article
Bhatia,S。癌症幸存者蒽环类心肌病的遗传学:JACC:心脏肿瘤学最新进展。JACC CardioOncol 2539-552(2020)。文章
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Wang, X. et al. Genome-wide association study identifies ROBO2 as a novel susceptibility gene for anthracycline-related cardiomyopathy in childhood cancer survivors. J. Clin. Oncol. 41, 1758–1769 (2023). This work presents an interesting GWAS finding for anthracycline-related cardiomyopathy with strong biological plausibility and may lead to precision approaches for prevention.Article .
Wang,X。等人。全基因组关联研究确定ROBO2是儿童癌症幸存者蒽环类相关心肌病的新型易感基因。J、 临床。Oncol公司。411758-1769(2023)。这项工作为蒽环类药物相关性心肌病提供了一个有趣的GWAS发现,具有很强的生物学合理性,并可能导致精确的预防方法。文章。
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Zhao, J. & Mommersteeg, M. T. M. Slit–Robo signalling in heart development. Cardiovasc. Res. 114, 794–804 (2018).Article
Zhao,J.&Mommersteeg,M.T.M.Slit–心脏发育中的机器人信号传导。心血管。第114794-804号决议(2018年)。文章
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Liu, Y. et al. Crosstalk between the activated Slit2–Robo1 pathway and TGF-β1 signalling promotes cardiac fibrosis. Esc. Heart Fail. 8, 447–460 (2021).Article
Liu,Y。等人。激活的Slit2-Robo1途径与TGF-β1信号传导之间的串扰促进心脏纤维化。Esc。心脏衰竭。8447-460(2021)。文章
PubMed
PubMed
Google Scholar
谷歌学者
Sapkota, Y. et al. A novel locus on 6p21.2 for cancer treatment-induced cardiac dysfunction among childhood cancer survivors. J. Natl Cancer Inst. 114, 1109–1116 (2022).Article
Sapkota,Y。等人。6p21.2上的一个新基因座,用于癌症治疗,在儿童癌症幸存者中引起心脏功能障碍。J、 国家癌症研究所1141109-1116(2022)。文章
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Sapkota, Y. et al. Genetic variants associated with therapy-related cardiomyopathy among childhood cancer survivors of African ancestry. Cancer Res. 81, 2556–2565 (2021). This study highlights a genetic variant associated with therapy-related cardiomyopathy with a much stronger risk in survivors of childhood cancer with African ancestry.Article .
Sapkota,Y.等人。非洲血统的儿童癌症幸存者中与治疗相关的心肌病相关的遗传变异。癌症研究812556-2565(2021)。这项研究强调了与治疗相关的心肌病相关的遗传变异,非洲血统的儿童癌症幸存者的风险要高得多。文章。
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Brown, A. L. & Richard, M. A. A role for genetics in racial disparities of therapy-related cardiomyopathy. Cancer Res. 81, 2272–2274 (2021).Article
Brown,A.L。和Richard,M.A。遗传学在治疗相关性心肌病种族差异中的作用。癌症研究812272-2274(2021)。文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Ehrhardt, M. J. et al. Systematic review and updated recommendations for cardiomyopathy surveillance for survivors of childhood, adolescent, and young adult cancer from the International Late Effects of Childhood Cancer Guideline Harmonization Group. Lancet Oncol. 24, e108–e120 (2023).Article .
Ehrhardt,M.J.等人,《国际儿童癌症晚期效应指南协调小组对儿童,青少年和年轻成人癌症幸存者的心肌病监测的系统评价和更新建议》。柳叶刀Oncol。24,e108–e120(2023)。文章。
PubMed
PubMed
Google Scholar
谷歌学者
Magdy, T. et al. Identification of drug transporter genomic variants and inhibitors that protect against doxorubicin-induced cardiotoxicity. Circulation 145, 279–294 (2022).Article
Magdy,T.等人。鉴定药物转运蛋白基因组变体和抑制剂,以防止阿霉素引起的心脏毒性。发行量145279–294(2022)。文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Aminkeng, F. et al. A coding variant in RARG confers susceptibility to anthracycline-induced cardiotoxicity in childhood cancer. Nat. Genet. 47, 1079–1084 (2015).Article
Aminkeng,F。等人。RARG中的编码变体赋予儿童癌症对蒽环类药物诱导的心脏毒性的易感性。纳特·吉内特。471079-1084(2015)。文章
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Magdy, T. et al. RARG variant predictive of doxorubicin-induced cardiotoxicity identifies a cardioprotective therapy. Cell Stem Cell 28, 2076–2089.e7 (2021).Article
Magdy,T。等人。预测多柔比星诱导的心脏毒性的RARG变体确定了心脏保护疗法。细胞干细胞282076–2089.e7(2021)。文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Fonoudi, H. et al. Functional validation of doxorubicin-induced cardiotoxicity-related genes. JACC CardioOncol 6, 38–50 (2024).Article
Fonoudi,H。等人。阿霉素诱导的心脏毒性相关基因的功能验证。JACC CardioOncol 6,38-50(2024)。文章
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Grandt, C. L. et al. Gene expression variability in long-term survivors of childhood cancer and cancer-free controls in response to ionizing irradiation. Mol. Med. 29, 41 (2023).Article
Grandt,C.L.等人。电离辐射对儿童癌症和无癌对照的长期幸存者的基因表达变异性。分子医学29,41(2023)。文章
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Jaiswal, S. & Ebert, B. L. Clonal hematopoiesis in human aging and disease. Science 366, eaan4673 (2019).Article
Jaiswal,S。&Ebert,B.L。人类衰老和疾病中的克隆造血。科学366,eaan4673(2019)。文章
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Gillis, N. K. et al. Clonal haemopoiesis and therapy-related myeloid malignancies in elderly patients: a proof-of-concept, case–control study. Lancet Oncol. 18, 112–121 (2017).Article
Gillis,N.K.等人。老年患者的克隆性造血和治疗相关的骨髓恶性肿瘤:概念验证,病例对照研究。柳叶刀Oncol。18112-121(2017)。文章
PubMed
PubMed
Google Scholar
谷歌学者
Takahashi, K. et al. Preleukaemic clonal haemopoiesis and risk of therapy-related myeloid neoplasms: a case–control study. Lancet Oncol. 18, 100–111 (2017).Article
Takahashi,K。等人。白血病前克隆性造血和治疗相关骨髓肿瘤的风险:病例对照研究。柳叶刀Oncol。18100-111(2017)。文章
PubMed
PubMed
Google Scholar
谷歌学者
Yan, C. et al. Clonal hematopoiesis and therapy-related myeloid neoplasms after autologous transplant for Hodgkin lymphoma. J. Clin. Oncol. 42, 2415–2424 (2024).Article
Yan,C.等。霍奇金淋巴瘤自体移植后的克隆性造血和治疗相关的骨髓肿瘤。J、 临床。Oncol公司。。文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Radivoyevitch, T. et al. Defining AML and MDS second cancer risk dynamics after diagnoses of first cancers treated or not with radiation. Leukemia 30, 285–294 (2016).Article
Radivoyevitch,T.等人定义了AML和MDS在诊断出第一次接受或未接受放射治疗的癌症后的第二次癌症风险动态。白血病30285-294(2016)。文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Schwartz, J. R. et al. The acquisition of molecular drivers in pediatric therapy-related myeloid neoplasms. Nat. Commun. 12, 985 (2021).Article
Schwartz,J.R.等人。儿科治疗相关骨髓肿瘤中分子驱动因素的获得。国家公社。12985(2021)。文章
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Bertrums, E. J. M. et al. Elevated mutational age in blood of children treated for cancer contributes to therapy-related myeloid neoplasms. Cancer Discov. 12, 1860–1872 (2022).CAS
Bertrums,E.J.M.等人。接受癌症治疗的儿童血液中突变年龄的升高有助于治疗相关的骨髓肿瘤。癌症发现。121860-1872(2022)。中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Coorens, T. H. H. et al. Clonal hematopoiesis and therapy-related myeloid neoplasms following neuroblastoma treatment. Blood 137, 2992–2997 (2021).Article
Coorens,T.H.H.等人。神经母细胞瘤治疗后的克隆性造血和治疗相关的骨髓肿瘤。血液1372992-2997(2021)。文章
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Bertrums, E. J. M. et al. Selective pressures of platinum compounds shape the evolution of therapy-related myeloid neoplasms. Nat. Commun. 15, 6025 (2024).Article
Bertrums,E.J.M.等人。铂化合物的选择压力影响治疗相关骨髓肿瘤的演变。国家公社。156025(2024)。文章
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Barnard, D. R. & Woods, W. G. Treatment-related myelodysplastic syndrome/acute myeloid leukemia in survivors of childhood cancer—an update. Leuk. Lymphoma 46, 651–663 (2005).Article
。白血病。淋巴瘤46651-663(2005)。文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Le, H. et al. Rearrangements of the MLL gene are influenced by DNA secondary structure, potentially mediated by topoisomerase II binding. Genes. Chromosomes Cancer 48, 806–815 (2009).Article
Le,H。等人。MLL基因的重排受DNA二级结构的影响,可能由拓扑异构酶II结合介导。基因。染色体癌48806-815(2009)。文章
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Coombs, C. C. et al. Therapy-related clonal hematopoiesis in patients with non-hematologic cancers is common and associated with adverse clinical outcomes. Cell Stem Cell 21, 374–382.e4 (2017).Article
。细胞干细胞21374-382.e4(2017)。文章
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Bolton, K. L. et al. Cancer therapy shapes the fitness landscape of clonal hematopoiesis. Nat. Genet. 52, 1219–1226 (2020).Article
Bolton,K.L.等人,《癌症治疗塑造了克隆造血的健康景观》。纳特·吉内特。521219-1226(2020)。文章
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Collord, G. et al. Clonal haematopoiesis is not prevalent in survivors of childhood cancer. Br. J. Haematol. 181, 537–539 (2018).Article
Collord,G。等人。克隆性造血在儿童癌症幸存者中并不普遍。Br.J.血液学。181537-539(2018)。文章
PubMed
PubMed
Google Scholar
谷歌学者
Novetsky Friedman, D. et al. Clonal hematopoiesis in survivors of childhood cancer. Blood Adv. 7, 4102–4106 (2023).Article
Novetsky-Friedman,D。等人。儿童癌症幸存者的克隆造血。血液杂志74102-4106(2023)。文章
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Bick, A. G. et al. Inherited causes of clonal haematopoiesis in 97,691 whole genomes. Nature 586, 763–768 (2020).Article
Bick,A.G.等人在97691个全基因组中遗传了克隆造血的原因。《自然》586763-768(2020)。文章
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Mauz-Körholz, C. et al. Pediatric Hodgkin lymphoma. J. Clin. Oncol. 33, 2975–2985 (2015).Article
Mauz-Körholz,C。等。小儿霍奇金淋巴瘤。J、 临床。Oncol公司。332975-2985(2015)。文章
PubMed
PubMed
Google Scholar
谷歌学者
Pich, O. et al. The mutational footprints of cancer therapies. Nat. Genet. 51, 1732–1740 (2019).Article
Pich,O.等人,《癌症治疗的突变足迹》。纳特·吉内特。511732-1740(2019)。文章
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
de Kanter, J. K. et al. Antiviral treatment causes a unique mutational signature in cancers of transplantation recipients. Cell Stem Cell 28, 1726–1739.e6 (2021).Article
de Kanter,J.K.等人。抗病毒治疗在移植受者的癌症中引起独特的突变特征。细胞干细胞281726-1739.e6(2021)。文章
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Choi, S. J. et al. Alteration of DNA methylation in gastric cancer with chemotherapy. J. Microbiol. Biotechnol. 27, 1367–1378 (2017).Article
Choi,S.J.等人。化疗对胃癌DNA甲基化的影响。J、 微生物。生物技术。271367-1378(2017)。文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Yao, S. et al. Impact of chemotherapy for breast cancer on leukocyte DNA methylation landscape and cognitive function: a prospective study. Clin. Epigenetics 11, 45 (2019).Article
Yao,S.等人。乳腺癌化疗对白细胞DNA甲基化景观和认知功能的影响:一项前瞻性研究。临床。表观遗传学11,45(2019)。文章
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Robinson, N. et al. Anti-cancer therapy is associated with long-term epigenomic changes in childhood cancer survivors. Br. J. Cancer 127, 288–300 (2022). This epigenetic study was conducted with survivors of childhood cancer from the UK.Article
抗癌治疗与儿童癌症幸存者的长期表观基因组变化有关。《癌症杂志》127288-300(2022)。这项表观遗传学研究是针对英国儿童癌症幸存者进行的
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Dong, Q. et al. Distinct DNA methylation signatures associated with blood lipids as exposures or outcomes among survivors of childhood cancer: a report from the St. Jude Lifetime Cohort. Clin. Epigenetics 15, 32 (2023).Article
Dong,Q。等人。与血脂相关的不同DNA甲基化特征作为儿童癌症幸存者的暴露或结果:来自圣裘德终身队列的报告。临床。表观遗传学15,32(2023)。文章
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Singh, P. et al. Identification of novel hypermethylated or hypomethylated CpG sites and genes associated with anthracycline-induced cardiomyopathy. Sci. Rep. 13, 12683 (2023).Article
Singh,P。等人。鉴定与蒽环类药物诱导的心肌病相关的新型高甲基化或低甲基化CpG位点和基因。科学。第13页,第12683页(2023年)。文章
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Song, N. et al. Blood DNA methylation signatures are associated with social determinants of health among survivors of childhood cancer. Epigenetics 17, 1389–1403 (2022).Article
Song,N.等人。血液DNA甲基化特征与儿童癌症幸存者健康的社会决定因素有关。表观遗传学171389-1403(2022)。文章
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Song, N. et al. Social-epigenetic mediators for racial disparities in pulmonary impairment among childhood cancer survivors. Cancer Commun. 43, 290–293 (2023).Article
。癌症社区。43290–293(2023)。文章
Google Scholar
谷歌学者
Singh, P. et al. Altered peripheral blood gene expression in childhood cancer survivors with anthracycline-induced cardiomyopathy—a COG-ALTE03N1 report. J. Am. Heart Assoc. 12, e029954 (2023).Article
Singh,P.等人。蒽环类药物诱导的心肌病儿童癌症幸存者外周血基因表达的改变-COG-ALTE03N1报告。J、 美国心脏协会第12号,e029954(2023)。文章
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Singh, P. et al. Haptoglobin gene expression and anthracycline-related cardiomyopathy in childhood cancer survivors: a COG-ALTE03N1 report. JACC CardioOncol 5, 392–401 (2023).Article
Singh,P。等人。儿童癌症幸存者的触珠蛋白基因表达和蒽环类相关心肌病:COG-ALTE03N1报告。JACC CardioOncol 5392-401(2023)。文章
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Chiavellini, P. et al. Aging and rejuvenation—a modular epigenome model. Aging 13, 4734–4746 (2021).Article
Chiavellini,P。等人,《衰老与复兴——一种模块化的表观基因组模型》。。文章
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Noroozi, R. et al. DNA methylation-based age clocks: from age prediction to age reversion. Ageing Res. Rev. 68, 101314 (2021).Article
基于DNA甲基化的年龄时钟:从年龄预测到年龄逆转。《老龄化决议》第68101314版(2021年)。文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Pun, F. W. et al. Hallmarks of aging-based dual-purpose disease and age-associated targets predicted using PandaOmics AI-powered discovery engine. Aging 14, 2475–2506 (2022).Article
Pun,F.W.等人。使用PandaOmics AI驱动的发现引擎预测的基于衰老的双重目的疾病和与年龄相关的目标的标志。年龄142475-2506(2022)。文章
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Noroozi, R. et al. Analysis of epigenetic clocks links yoga, sleep, education, reduced meat intake, coffee, and a SOCS2 gene variant to slower epigenetic aging. Geroscience 46, 2583–2604 (2024).Article
表观遗传钟的分析将瑜伽、睡眠、教育、减少肉类摄入、咖啡和SOCS2基因变异与减缓表观遗传衰老联系起来。Geroscience 462583-2604(2024)。文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Franco, I., Revechon, G. & Eriksson, M. Challenges of proving a causal role of somatic mutations in the aging process. Aging Cell 21, e13613 (2022).Article
Franco,I.,Revechon,G。&Eriksson,M。证明体细胞突变在衰老过程中的因果作用的挑战。衰老细胞21,e13613(2022)。文章
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
López-Otín, C., Blasco, M. A., Partridge, L., Serrano, M. & Kroemer, G. Hallmarks of aging: an expanding universe. Cell 186, 243–278 (2023).Article
洛佩斯·奥丁(López Otín),马萨诸塞州布拉斯科(Blasco),帕特里奇(Partridge),L。塞拉诺(Serrano),M。和克罗默(Kroemer),G。衰老的标志:膨胀的宇宙。细胞186243-278(2023)。文章
PubMed
PubMed
Google Scholar
谷歌学者
Hannum, G. et al. Genome-wide methylation profiles reveal quantitative views of human aging rates. Mol. Cell 49, 359–367 (2013).Article
Hannum,G。等人。全基因组甲基化谱揭示了人类衰老率的定量观点。分子细胞49359-367(2013)。文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Horvath, S. DNA methylation age of human tissues and cell types. Genome Biol. 14, R115 (2013).Article
Horvath,S。人体组织和细胞类型的DNA甲基化年龄。基因组生物学。14,R115(2013)。文章
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Levine, M. E. et al. An epigenetic biomarker of aging for lifespan and healthspan. Aging 10, 573–591 (2018).Article
Levine,M.E.等人。衰老对寿命和健康的表观遗传生物标志物。年龄10573-591(2018)。文章
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Lu, A. T. et al. DNA methylation GrimAge strongly predicts lifespan and healthspan. Aging 11, 303–327 (2019).Article
Lu,A.T.等人,DNA甲基化GrimAge强烈预测寿命和健康寿命。年龄11303-327(2019)。文章
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Belsky, D. W. et al. DunedinPACE, a DNA methylation biomarker of the pace of aging. eLife 11, e73420 (2022).Article
Belsky,D.W.等人,《衰老速度的DNA甲基化生物标志物DunedinPACE》。eLife 11,e73420(2022)。文章
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Horvath, S. & Raj, K. DNA methylation-based biomarkers and the epigenetic clock theory of ageing. Nat. Rev. Genet. 19, 371–384 (2018).Article
Horvath,S。&Raj,K。基于DNA甲基化的生物标志物和衰老的表观遗传时钟理论。Genet自然Rev。19371-384(2018)。文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Garatachea, N. et al. Exercise attenuates the major hallmarks of aging. Rejuvenation Res. 18, 57–89 (2015).Article
。复兴决议18,57-89(2015)。文章
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Ros, M. & Carrascosa, J. M. Current nutritional and pharmacological anti-aging interventions. Biochim. Biophys. Acta Mol. Basis Dis. 1866, 165612 (2020).Article
Ros,M。&Carrascosa,J.M。目前的营养和药理抗衰老干预措施。生物化学。生物物理。分子基础学报。1866165612(2020)。文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Fitzgerald, K. N. et al. Potential reversal of epigenetic age using a diet and lifestyle intervention: a pilot randomized clinical trial. Aging 13, 9419–9432 (2021).Article
Fitzgerald,K.N.等人,《饮食和生活方式干预对表观遗传年龄的潜在逆转:一项试点随机临床试验》。年龄139419-9432(2021)。文章
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Fiorito, G. et al. DNA methylation-based biomarkers of aging were slowed down in a two-year diet and physical activity intervention trial: the DAMA study. Aging Cell 20, e13439 (2021).Article
在一项为期两年的饮食和身体活动干预试验中,基于DNA甲基化的衰老生物标志物被减缓:DAMA研究。衰老细胞20,e13439(2021)。文章
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Tenchov, R., Sasso, J. M., Wang, X. & Zhou, Q. A. Antiaging strategies and remedies: a landscape of research progress and promise. ACS Chem. Neurosci. 15, 408–446 (2024).Article
Tenchov,R.,Sasso,J.M.,Wang,X.&Zhou,Q.A。抗衰老策略和补救措施:研究进展和前景。ACS化学。神经科学。15408-446(2024)。文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Schellnegger, M., Hofmann, E., Carnieletto, M. & Kamolz, L. P. Unlocking longevity: the role of telomeres and its targeting interventions. Front. Aging 5, 1339317 (2024).Article
Schellnegger,M.,Hofmann,E.,Carnieletto,M。&Kamolz,L.P。解锁寿命:端粒的作用及其靶向干预。正面。年龄51339317(2024)。文章
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Hudson, M. M. et al. Approach for classification and severity grading of long-term and late-onset health events among childhood cancer survivors in the St. Jude Lifetime Cohort. Cancer Epidemiol. Biomark. Prev. 26, 666–674 (2017).Article
Hudson,M.M.等人,《圣裘德终身队列中儿童癌症幸存者长期和迟发健康事件的分类和严重程度分级方法》。癌症流行病学。生物标志物。26666-674(2017)。文章
Google Scholar
谷歌学者
Qin, N. et al. Epigenetic age acceleration and chronic health conditions among adult survivors of childhood cancer. J. Natl Cancer Inst. 113, 597–605 (2021).Article
。J、 国家癌症研究所113597-605(2021)。文章
PubMed
PubMed
Google Scholar
谷歌学者
Dong, Q. et al. Genome-wide association studies identify novel genetic loci for epigenetic age acceleration among survivors of childhood cancer. Genome Med. 14, 32 (2022).Article
Dong,Q。等人。全基因组关联研究确定了儿童癌症幸存者表观遗传年龄加速的新基因位点。基因组医学14,32(2022)。文章
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Peloso, G. M. et al. Common genetic variation in multiple metabolic pathways influences susceptibility to low HDL-cholesterol and coronary heart disease. J. Lipid Res. 51, 3524–3532 (2010).Article
Peloso,G.M.等人。多种代谢途径中常见的遗传变异会影响对低HDL胆固醇和冠心病的易感性。J、 脂质研究513524-3532(2010)。文章
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Gaunt, T. R. et al. Systematic identification of genetic influences on methylation across the human life course. Genome Biol. 17, 61 (2016).Article
Gaunt,T.R.等人。系统鉴定人类生命过程中基因对甲基化的影响。基因组生物学。17,61(2016)。文章
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Gibson, J. et al. A meta-analysis of genome-wide association studies of epigenetic age acceleration. PLoS Genet. 15, e1008104 (2019).Article
吉布森,J。等人。表观遗传年龄加速的全基因组关联研究的荟萃分析。PLoS Genet。15,e1008104(2019)。文章
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Flohr Svendsen, A. et al. A comprehensive transcriptome signature of murine hematopoietic stem cell aging. Blood 138, 439–451 (2021).Article
Flohr Svendsen,A。等人。小鼠造血干细胞衰老的综合转录组特征。血液138439-451(2021)。文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Lu, A. T. et al. GWAS of epigenetic aging rates in blood reveals a critical role for TERT. Nat. Commun. 9, 387 (2018).Article
Lu,A.T.等人,血液中表观遗传衰老率的GWAS揭示了TERT的关键作用。国家公社。9387(2018)。文章
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Plonski, N. M. et al. Epigenetic age in peripheral blood among children, adolescent, and adult survivors of childhood cancer. JAMA Netw. Open 6, e2310325 (2023). This study reports that EAA is associated with morbidity and premature mortality across the chronological age spectrum among survivors of childhood cancer.Article .
Plonski,N.M.等人。儿童、青少年和成年癌症幸存者外周血中的表观遗传年龄。JAMA网络。开放6,e2310325(2023)。这项研究报告说,EAA与儿童癌症幸存者的发病率和过早死亡率有关。文章。
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Williams, A. M. et al. Deficit accumulation index and biological markers of aging in survivors of childhood cancer. JAMA Netw. Open 6, e2344015 (2023).Article
Williams,A.M.等人,《儿童癌症幸存者的缺陷累积指数和衰老的生物学标志物》。JAMA网络。打开6,e2344015(2023)。文章
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Plonski, N. M. et al. Health-related quality of life and DNA methylation-based aging biomarkers among survivors of childhood cancer. J. Natl Cancer Inst. 116, 1116–1125 (2024).Article
Plonski,N.M.等人。儿童癌症幸存者中与健康相关的生活质量和基于DNA甲基化的衰老生物标志物。J、 国家癌症研究所1161116-1125(2024)。文章
PubMed
PubMed
Google Scholar
谷歌学者
Chen, C. et al. Race and ethnicity, socioeconomic factors, and epigenetic age acceleration in survivors of childhood cancer. JAMA Netw. Open 7, e2419771 (2024).Article
Chen,C.等人。儿童癌症幸存者的种族和种族,社会经济因素和表观遗传年龄加速。JAMA网络。开放7,e2419771(2024)。文章
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Gehle, S. C. et al. Accelerated epigenetic aging and myopenia in young adult cancer survivors. Cancer Med. 12, 12149–12160 (2023).Article
Gehle,S.C.等人加速了年轻成年癌症幸存者的表观遗传衰老和肌肉减少症。癌症医学12149-12160(2023)。文章
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Guida, J. L. et al. Associations of seven measures of biological age acceleration with frailty and all-cause mortality among adult survivors of childhood cancer in the St. Jude Lifetime Cohort. Nat. Cancer 5, 731–741 (2024).Article
Guida,J.L.等人,《圣裘德终身队列中儿童癌症成年幸存者的七项生物年龄加速指标与虚弱和全因死亡率的关系》。《自然癌症》5731-741(2024)。文章
PubMed
PubMed
Google Scholar
谷歌学者
Song, N. et al. Shortened leukocyte telomere length associates with an increased prevalence of chronic health conditions among survivors of childhood cancer: a report from the St. Jude Lifetime Cohort. Clin. Cancer Res. 26, 2362–2371 (2020).Article
Song,N.等人,《缩短白细胞端粒长度与儿童癌症幸存者中慢性健康状况的患病率增加有关:来自圣裘德终身队列的报告》。临床。。文章
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Gramatges, M. M. et al. Telomere content and risk of second malignant neoplasm in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. Clin. Cancer Res. 20, 904–911 (2014).Article
Gramatges,M.M.等人,《儿童癌症幸存者端粒含量与第二次恶性肿瘤风险:儿童癌症幸存者研究报告》。临床。《癌症研究》20904-911(2014)。文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Mengel-From, J. et al. Mitochondrial DNA copy number in peripheral blood cells declines with age and is associated with general health among elderly. Hum. Genet. 133, 1149–1159 (2014).Article
Mengel From,J.等人。外周血细胞中的线粒体DNA拷贝数随着年龄的增长而下降,并且与老年人的总体健康有关。嗯,Genet。1331149-1159(2014)。文章
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Zhang, R., Wang, Y., Ye, K., Picard, M. & Gu, Z. Independent impacts of aging on mitochondrial DNA quantity and quality in humans. BMC Genomics 18, 890 (2017).Article
Zhang,R.,Wang,Y.,Ye,K.,Picard,M。&Gu,Z。衰老对人类线粒体DNA数量和质量的独立影响。BMC Genomics 18890(2017)。文章
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
McCastlain, K. et al. The association of mitochondrial copy number with sarcopenia in adult survivors of childhood cancer. J. Natl Cancer Inst. 113, 1570–1580 (2021).Article
McCastlain,K.等人。儿童癌症成年幸存者线粒体拷贝数与肌肉减少症的关系。J、 国家癌症研究所1131570-1580(2021)。文章
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Villani, A. et al. Biochemical and imaging surveillance in germline TP53 mutation carriers with Li–Fraumeni syndrome: 11 year follow-up of a prospective observational study. Lancet Oncol. 17, 1295–1305 (2016).Article
Villani,A。等人。Li-Fraumeni综合征种系TP53突变携带者的生化和影像学监测:一项前瞻性观察性研究的11年随访。柳叶刀Oncol。171295-1305(2016)。文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Miller, D. T. et al. ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG). Genet. Med. 23, 1381–1390 (2021).Article
Miller,D.T.等人,《ACMG SF v3.0临床外显子组和基因组测序次要发现报告清单:美国医学遗传学和基因组学学院(ACMG)的政策声明》。基因。医学231381-1390(2021)。文章
PubMed
PubMed
Google Scholar
谷歌学者
Song, N. et al. Polygenic risk score improves risk stratification and prediction of subsequent thyroid cancer after childhood cancer. Cancer Epidemiol. Biomark. Prev. 30, 2096–2104 (2021).Article
Song,N。等人。多基因风险评分改善了儿童癌症后的风险分层和随后甲状腺癌的预测。癌症流行病学。生物标志物。302096-2104(2021)。文章
CAS
中科院
Google Scholar
谷歌学者
Chaix, M. A. et al. Machine learning identifies clinical and genetic factors associated with anthracycline cardiotoxicity in pediatric cancer survivors. JACC CardioOncol 2, 690–706 (2020). This study applies a machine learning approach to generate a risk prediction model incorporating clinical and genetic risk factors.
Chaix,M.A.等人的机器学习确定了与儿科癌症幸存者蒽环类药物心脏毒性相关的临床和遗传因素。JACC CardioOncol 2690–706(2020)。这项研究应用机器学习方法来生成包含临床和遗传风险因素的风险预测模型。
The model also informs on novel cardio-protective drug targets.Article .
该模型还提供了新的心脏保护药物靶标。文章。
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Im, C. et al. Leveraging therapy-specific polygenic risk scores to predict restrictive lung defects in childhood cancer survivors. Cancer Res. 82, 2940–2950 (2022).Article
Im,C.等人利用治疗特异性多基因风险评分来预测儿童癌症幸存者的限制性肺缺陷。癌症研究822940-2950(2022)。文章
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Sapkota, Y. et al. Genetic risk score enhances the risk prediction of severe obesity in adult survivors of childhood cancer. Nat. Med. 28, 1590–1598 (2022).Article
Sapkota,Y。等人。遗传风险评分增强了儿童癌症成年幸存者严重肥胖的风险预测。《自然医学》281590-1598(2022)。文章
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Klein, E. A. et al. Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set. Ann. Oncol. 32, 1167–1177 (2021).Article
Klein,E.A。等人。使用独立验证集对基于靶向甲基化的多癌症早期检测测试进行临床验证。安科。321167-1177(2021)。文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
North, B. J. & Sinclair, D. A. The intersection between aging and cardiovascular disease. Circ. Res. 110, 1097–1108 (2012).Article
North,B.J。&Sinclair,D.A。衰老与心血管疾病之间的交叉。保监会。第1101097-1108号决议(2012年)。文章
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Rodgers, J. L. et al. Cardiovascular risks associated with gender and aging. J. Cardiovasc. Dev. Dis. 6, 19 (2019).CAS
Rodgers,J.L.等人,《与性别和衰老相关的心血管风险》。J、 心血管。偏差Dis。6,19(2019)。中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Xia, P. et al. RBL2 regulates cardiac sensitivity to anthracycline chemotherapy. JACC CardioOncol 5, 360–373 (2023).Article
Xia,P。等人。RBL2调节心脏对蒽环类化疗的敏感性。JACC CardioOncol 5360-373(2023)。文章
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Matt, G. Y. et al. St. Jude Survivorship Portal: sharing and analyzing large clinical and genomic datasets from pediatric cancer survivors. Cancer Discov. 14, 1403–1417 (2024).Article
Matt,G.Y.等人,《St.Jude Survivorship Portal:共享和分析儿科癌症幸存者的大型临床和基因组数据集》。癌症发现。141403-1417(2024)。文章
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Marcoux, S. et al. The PETALE study: late adverse effects and biomarkers in childhood acute lymphoblastic leukemia survivors. Pediatr. Blood Cancer 64, e26361 (2017).Article
Marcoux,S.等人,《PETALE研究:儿童急性淋巴细胞白血病幸存者的晚期不良反应和生物标志物》。。血癌64e26361(2017)。文章
Google Scholar
谷歌学者
Howell, C. R. et al. Cohort profile: the St. Jude Lifetime Cohort Study (SJLIFE) for paediatric cancer survivors. Int. J. Epidemiol. 50, 39–49 (2021).Article
Howell,C.R.等人。队列概况:针对儿科癌症幸存者的圣裘德终身队列研究(SJLIFE)。国际流行病学杂志。50,39-49(2021)。文章
PubMed
PubMed
Google Scholar
谷歌学者
Brooke, R. J. et al. A high-risk haplotype for premature menopause in childhood cancer survivors exposed to gonadotoxic therapy. J. Natl Cancer Inst. 110, 895–904 (2018).Article
Brooke,R.J.等人。暴露于性腺毒性治疗的儿童癌症幸存者过早绝经的高风险单倍型。J、 国家癌症研究所110895-904(2018)。文章
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Sapkota, Y. et al. A novel locus predicts spermatogenic recovery among childhood cancer survivors exposed to alkylating agents. Cancer Res. 80, 3755–3764 (2020).Article
Sapkota,Y。等人。一个新的基因座预测暴露于烷化剂的儿童癌症幸存者的生精恢复。癌症研究803755-3764(2020)。文章
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Im, C. et al. Trans-ancestral genetic risk factors for treatment-related type 2 diabetes mellitus in survivors of childhood cancer. J. Clin. Oncol. 42, 2306–2316 (2024).Article
Im,C.等人。儿童癌症幸存者治疗相关2型糖尿病的跨祖先遗传危险因素。J、 临床。Oncol公司。422306-2316(2024)。文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Im, C. et al. Development and validation of age-specific risk prediction models for primary ovarian insufficiency in long-term survivors of childhood cancer: a report from the Childhood Cancer Survivor Study and St Jude Lifetime Cohort. Lancet Oncol. 24, 1434–1442 (2023).Article
Im,C.等人。儿童癌症长期幸存者原发性卵巢功能不全的年龄特异性风险预测模型的开发和验证:儿童癌症幸存者研究和圣裘德终身队列的报告。柳叶刀Oncol。241434-1442(2023)。文章
PubMed
PubMed
Google Scholar
谷歌学者
Daniel, S. et al. T cell epigenetic remodeling and accelerated epigenetic aging are linked to long-term immune alterations in childhood cancer survivors. Clin. Epigenetics 10, 138 (2018).Article
Daniel,S。等人。T细胞表观遗传重塑和加速的表观遗传衰老与儿童癌症幸存者的长期免疫改变有关。临床。表观遗传学10138(2018)。文章
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Lupo, P. J. et al. DNA methylation and obesity in survivors of pediatric acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. Genes Chromosomes Cancer 58, 52–59 (2019).Article
Lupo,P.J.等人,《儿童急性淋巴细胞白血病幸存者的DNA甲基化和肥胖:儿童癌症幸存者研究报告》。基因染色体癌症58,52-59(2019)。文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Download referencesAcknowledgementsThe authors thank L. Robison, G. Armstrong, C. Im, J. Klco and Y. Sapkota for help in reviewing and providing critical feedback on the manuscript. They thank Q. Dong, K. Hagiwara, X. Meng and N. Plonski for helping with preparation of figures and tables.
下载参考文献致谢作者感谢L.Robison,G.Armstrong,C.Im,J.Klco和Y.Sapkota在审阅稿件和提供批判性反馈方面的帮助。他们感谢Q.Dong、K.Hagiwara、X.Meng和N.Plonski帮助编制图表。
This study was supported, in part, by National Cancer Institute (NCI) grants R01CA216391 to J.Z. and R01CA290112, R01CA279520 and R01CA283333 to Z.W. The study is also supported by American Lebanese Syrian Associated Charities (ALSAC).Author informationAuthors and AffiliationsDepartment of Epidemiology and Cancer Control, St.
这项研究得到了国家癌症研究所(NCI)向J.Z.授予R01CA216391,向Z.W授予R01CA290112,R01CA279520和R01CA28333的部分支持。这项研究也得到了美国黎巴嫩叙利亚联合慈善机构(ALSAC)的支持。。
Jude Children’s Research Hospital, Memphis, TN, USAZhaoming WangDepartment of Computational Biology, St. Jude Children’s Research Hospital, Memphis, TN, USAZhaoming Wang & Jinghui ZhangAuthorsZhaoming WangView author publicationsYou can also search for this author in.
美国田纳西州孟菲斯裘德儿童研究医院王兆明美国田纳西州孟菲斯圣裘德儿童研究医院计算生物学系王兆明和张景辉作者王兆明观点作者出版物您也可以在中搜索这位作者。
PubMed Google ScholarJinghui ZhangView author publicationsYou can also search for this author in
PubMed谷歌学者张景辉查看作者出版物您也可以在
PubMed Google ScholarContributionsThe authors contributed equally to all aspects of the article.Corresponding authorsCorrespondence to
PubMed谷歌学术贡献作者对文章的各个方面都做出了同样的贡献。通讯作者通讯
Zhaoming Wang or Jinghui Zhang.Ethics declarations
王兆明或张景辉。道德宣言
Competing interests
相互竞争的利益
The authors declare no competing interests.
作者声明没有利益冲突。
Peer review
同行评审
Peer review information
同行评审信息
Nature Reviews Cancer thanks Jaume Mora, Javid Moslehi and Ruben van Boxtel for their contribution to the peer review of this work.
《自然评论》癌症感谢Jaume Mora,Javid Moslehi和Ruben van Boxtel为这项工作的同行评审做出的贡献。
Additional informationPublisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.Related linksALTE03N1: https://clinicaltrials.gov/study/NCT00082745dbGaP: https://dbgap.ncbi.nlm.nih.govEuropean Genome–Phenome Archive (EGA): https://ega-archive.org/Onco-Aging Consortium (OAC): https://www.cancer.gov/about-nci/organization/dcb/research-programs/oacSt.
Additional informationPublisher的注释Springer Nature在已发布的地图和机构隶属关系中的管辖权主张方面保持中立。相关链接Salte03N1:https://clinicaltrials.gov/study/NCT00082745dbGaP:(笑声)https://dbgap.ncbi.nlm.nih.govEuropean基因组-现象组档案(EGA):https://ega-archive.org/Onco-Aging联合体(OAC):https://www.cancer.gov/about-nci/organization/dcb/research-programs/oacSt.
Jude Cloud: https://platform.stjude.cloudSt. Jude Survivorship Portal: https://viz.stjude.cloud/cancer-survivorship/visualization/st-jude-survivorship-portal~18The Surveillance, Epidemiology, and End Results (SEER) Program: https://seer.cancer.gov/GlossaryArea deprivation index.
https://platform.stjude.cloudSt.Jude Survivorship门户:https://viz.stjude.cloud/cancer-survivorship/visualization/st-jude-survivorship-portal约18监测、流行病学和最终结果(SEER)计划:https://seer.cancer.gov/GlossaryArea剥夺指数。
A multidimensional evaluation of socio-economic conditions for a geographical region.
。
Cardiomyopathy
心肌病
A disease that affects the heart muscle, making it difficult for the heart to pump blood to the rest of the body.
一种影响心肌的疾病,使心脏难以将血液泵送到身体的其他部位。
Clonal haematopoiesis
克隆造血
(CH). A condition that is characterized by the outsized contribution of expanded clones of haematopoietic stem and progenitor cells (HSPCs) to blood cell production.
(CH)。一种以造血干细胞和祖细胞(HSPC)扩增克隆对血细胞产生的巨大贡献为特征的疾病。
Effect sizes
效果大小
Quantitative measurements of the magnitude of a difference or association between variables.
变量之间差异或关联程度的定量测量。
Epigenetic clocks
表观遗传钟
Tools that measure biological age based on DNA methylation patterns.
基于DNA甲基化模式测量生物年龄的工具。
Expression quantitative trait locus
表达数量性状基因座
A genetic variant that affects the expression of one or more genes.
影响一个或多个基因表达的遗传变异。
Genome-wide association studies
全基因组关联研究
(GWAS). A research method that compares the genomes of many people to identify genetic markers associated with a disease or trait.
(GWAS)。。
Genotoxicities
基因毒性
The ability of a chemical or physical agent to damage a cell’s DNA, which can lead to mutations and modifications.
化学或物理因素破坏细胞DNA的能力,这可能导致突变和修饰。
Haplotype
单倍型
A group of genetic variants on a single chromosome that are inherited from the same parent.
从同一亲本遗传的单个染色体上的一组遗传变异。
Hypercholesterolaemia
高胆固醇血症
A condition with abnormally high levels of cholesterol in the blood.
血液中胆固醇含量异常高的病症。
Hypertriglyceridaemia
高甘油三酯血症
A condition with abnormally high levels of triglycerides (TGs) in the blood.
血液中甘油三酯(TGs)含量异常高的病症。
Minor allele frequency
次等位基因频率
(MAF). The frequency at which the less common allele (that is, the ‘minor allele’) occurs within a specific population.
(MAF)。不太常见的等位基因(即“次要等位基因”)在特定人群中出现的频率。
Myopenia
肌肉减少
A substantial amount of muscle loss.
大量肌肉损失。
Odds ratio
优势比
A statistical measurement that shows how strongly an event is associated with an exposure.
一种统计测量,显示事件与暴露的关联程度。
Ototoxic effects
耳毒性作用
Damage to the inner ear that can cause hearing or balance problems.
内耳受损,可能导致听力或平衡问题。
Outcome ascertainment
结果确定
A process of identifying and classifying relevant events (for example, diseases).
。
Sarcopenia
肌肉减少症
A condition characterized by loss of muscle mass, strength and function.
以肌肉质量、力量和功能丧失为特征的疾病。
Single nucleotide polymorphism
(SNP). A variant in a DNA sequence where a single nucleotide is different from the reference sequence.
(SNP)。DNA序列中的变体,其中单个核苷酸与参考序列不同。
Splicing quantitative trait locus
剪接数量性状基因座
A genetic variant that regulates how pre-mRNA for a gene is spliced.
调节基因前体mRNA剪接方式的遗传变异。
Trans-ancestral replication
跨祖先复制
A method for identifying genetic risk variants across different ancestries.
一种识别不同祖先遗传风险变异的方法。
Variant allele fraction
变异等位基因分数
(VAF). A measure of the proportion of variant alleles in a genetic locus by dividing the number of sequence reads harbouring a specific variant by the total number of reads at that genomic location.
(VAF)。通过将携带特定变体的序列读数除以该基因组位置的读数总数来衡量遗传基因座中变异等位基因的比例。
Rights and permissionsSpringer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.Reprints and permissionsAbout this articleCite this articleWang, Z., Zhang, J.
权利和许可Pringer Nature或其许可人(例如协会或其他合作伙伴)根据与作者或其他权利持有人的出版协议对本文拥有专有权;本文接受稿件版本的作者自行存档仅受此类出版协议和适用法律的条款管辖。转载和许可本文引用本文Wang,Z.,Zhang,J。
Genetic and epigenetic bases of long-term adverse effects of childhood cancer therapy..
儿童癌症治疗长期不良反应的遗传和表观遗传基础。。
Nat Rev Cancer (2024). https://doi.org/10.1038/s41568-024-00768-6Download citationAccepted: 01 October 2024Published: 07 November 2024DOI: https://doi.org/10.1038/s41568-024-00768-6Share this articleAnyone you share the following link with will be able to read this content:Get shareable linkSorry, a shareable link is not currently available for this article.Copy to clipboard.
Nat Rev Cancer(2024)。https://doi.org/10.1038/s41568-024-00768-6Download引文接受日期:2024年10月1日发布日期:2024年11月7日OI:https://doi.org/10.1038/s41568-024-00768-6Share本文与您共享以下链接的任何人都可以阅读此内容:获取可共享链接对不起,本文目前没有可共享的链接。复制到剪贴板。
Provided by the Springer Nature SharedIt content-sharing initiative
由Springer Nature SharedIt内容共享计划提供